CNS Pharmaceuticals Inc. (CNSP) upgraded Issued by Wall Street Gurus – News Heater
Home  »  Companies   »  CNS Pharmaceuticals Inc. (CNSP) upgraded Issued by...

CNS Pharmaceuticals Inc. (CNSP) upgraded Issued by Wall Street Gurus

CNS Pharmaceuticals Inc. (NASDAQ:CNSP) went up by 17.86% from its latest closing price compared to the recent 1-year high of $2.68. The company’s stock price has collected 4.87% of gains in the last five trading sessions.

Is It Worth Investing in CNS Pharmaceuticals Inc. (NASDAQ :CNSP) Right Now?

Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for CNS Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $1.00, which is $5.67 above the current price. CNSP currently public float of 29.57M and currently shorts hold a 1.79% ratio of that float. Today, the average trading volume of CNSP was 705.74K shares.

CNSP’s Market Performance

CNSP stocks went up by 4.87% for the week, with a monthly jump of 1.45% and a quarterly performance of -17.65%, while its annual performance rate touched -86.47%. The volatility ratio for the week stands at 8.27% while the volatility levels for the past 30 days are set at 11.40% for CNS Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is 12.27% for CNSP stocks with a simple moving average of -56.12% for the last 200 days.

Analysts’ Opinion of CNSP

Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see CNSP reach a price target of $11. The rating they have provided for CNSP stocks is “Buy” according to the report published on August 24th, 2020.

CNSP Trading at 5.36% from the 50-Day Moving Average

After a stumble in the market that brought CNSP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.69% of loss for the given period.

Volatility was left at 11.40%, however, over the last 30 days, the volatility rate increased by 8.27%, as shares surge +19.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.62% lower at present.

During the last 5 trading sessions, CNSP rose by +23.91%, which changed the moving average for the period of 200-days by -78.88% in comparison to the 20-day moving average, which settled at $0.2967. In addition, CNS Pharmaceuticals Inc. saw -60.14% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CNSP starting from Downs Christopher, who purchase 5,000 shares at the price of $0.94 back on Dec 06. After this action, Downs Christopher now owns 151,500 shares of CNS Pharmaceuticals Inc., valued at $4,702 using the latest closing price.

Downs Christopher, the Chief Financial Officer of CNS Pharmaceuticals Inc., purchase 4,500 shares at $1.15 during a trade that took place back on Nov 19, which means that Downs Christopher is holding 146,500 shares at $5,192 based on the most recent closing price.

Stock Fundamentals for CNSP

Equity return is now at value -123.10, with -104.90 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.50.

CarLotz Inc. (LOTZ) Just Got Our Attention

CarLotz Inc. (NASDAQ:LOTZ) went down by -8.00% from its latest closing price compared to the recent 1-year high of $5.81. The company’s stock price has